We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LMB:NASDAQLimbach Holdings, Inc. Analysis

Data as of 2026-05-24 - not real-time

$71.36

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Limbach Holdings (LMB) is trading at $71.36, well below its 20‑day, 50‑day and 200‑day SMAs of $82.5, $83.2 and $88.4, indicating a bearish price trend. The RSI of 39.9 hints at near‑oversold conditions, yet the MACD histogram is negative and the signal line is bearish, reinforcing downside momentum. Volume is on a decreasing trend and 30‑day volatility is extreme at 133%, while a beta above 1.3 suggests the stock moves more sharply than the market. Valuation metrics show a trailing PE of 26 versus an industry average of 29.7, but the DCF fair value of $19.4 makes the current price appear overvalued with a 62% upside/downside gap. Forward earnings expectations are brighter, reflected in a forward PE of 14 and a projected EPS of $5.09, supporting a growth narrative. Fundamentals reveal modest revenue growth of 4.3%, a profit margin of 5% and a solid ROE of 18.6%, though operating margins are thin and debt‑to‑equity sits at 38.9%, indicating leverage risk. Recent Q1 2026 results beat revenue forecasts and delivered a non‑GAAP EPS of $0.64, reinforcing the company’s ability to exceed expectations despite a year‑over‑year EPS decline. The firm’s positioning in data‑center infrastructure projects adds a strategic growth catalyst. Overall, the stock balances bearish technical signals with improving earnings outlook and sector‑specific opportunities.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators (price below SMAs, negative MACD)
  • High volatility and decreasing volume
  • Recent earnings beat but EPS decline YoY

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward PE of 14 indicating earnings acceleration
  • Strategic exposure to data‑center infrastructure demand
  • Solid ROE and profit margin despite thin operating margin

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Overvaluation relative to DCF fair value
  • Sustained leverage (debt‑to‑equity ~39%)
  • Cyclical nature of building‑products sector

Key Metrics & Analysis

Financial Health

Revenue Growth4.30%
Profit Margin5.09%
P/E Ratio26.0
ROE18.59%
ROA7.78%
Debt/Equity38.95
P/B Ratio4.3
Op. Cash Flow$35.6M
Free Cash Flow$18.6M
Industry P/E29.7

Technical Analysis

TrendBearish
RSI39.9
Support$70.25
Resistance$114.95
MA 20$82.54
MA 50$83.24
MA 200$88.43
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$19.37
Target Price$115.60
Upside/Downside62.00%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.35
Volatility133.21%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.